Michael Chuong: Excited that our phase 1 trial of ablative reRT is open

Michael Chuong, Lead GI Radiation Oncologist at Miami Cancer Institute, shared on X:

“Excited our phase 1 trial of ablative reRT is open at the Miami Cancer Institute Research. .

• Based on our data (PMID: 35146215)
• 50 Gy/5 fx
•  Primary/metastatic lesions in abdomen/pelvis
• GI abutment ok, not invasion
• Maybe reRT can be more than just palliative?”

Source: Michael Chuong/X